Published in J Am Coll Cardiol on November 15, 2001
One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol (2007) 1.35
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol (2001) 1.19
Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol (2005) 0.88
Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography. Clin Res Cardiol (2010) 0.81
Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med (1999) 5.09
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med (2000) 4.30
A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell (1997) 3.65
Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation (1995) 3.20
Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst (1991) 3.07
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst (1992) 2.82
The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev (1998) 2.72
The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development (1999) 2.46
Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol (1990) 2.29
Randomised controlled trial of computer assisted management of hypertension in primary care. Br Med J (Clin Res Ed) (1986) 2.24
Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis (1985) 2.21
Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study. J Thromb Haemost (2009) 2.16
Access to medical records for research purposes: varying perceptions across research ethics boards. J Med Ethics (2008) 2.09
Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development (1997) 2.01
Lymphohematopoietic cancer in styrene-butadiene polymerization workers. Am J Epidemiol (1992) 1.95
Morphology of the human mitral valve. I. Chordae tendineae: a new classification. Circulation (1970) 1.86
The transcription factor HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis. Development (1998) 1.85
Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation (1999) 1.76
Validation of novel imaging methodologies for use as cancer clinical trial end-points. Eur J Cancer (2008) 1.73
Idiopathic medial aortopathy and arteriopathy. Am J Med (1968) 1.70
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol (2001) 1.68
Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev (1998) 1.65
Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. J Am Coll Cardiol (1992) 1.62
Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J Clin Oncol (1997) 1.60
Mortality of workers in styrene-butadiene polymer production. J Occup Med (1987) 1.59
Sudden, severe aortic insufficiency. Circulation (1965) 1.59
Morphology of the human mitral valve. II. The value leaflets. Circulation (1970) 1.57
Discrimination between Rb+ and K+ by Escherichia coli. Biochim Biophys Acta (1977) 1.57
His Bundle electrogram in bundle-branch block. Circulation (1972) 1.57
Bilateral angle-closure glaucoma in association with the acquired immune deficiency syndrome. Am J Ophthalmol (1986) 1.54
Large Virchow-Robin spaces: MR-clinical correlation. AJNR Am J Neuroradiol (1989) 1.53
Reliability and reproducibility of two dimensional echocardiograph measurement of the stenotic mitral valve orifice area. Am J Cardiol (1979) 1.47
Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol (1997) 1.46
Intrapericardial aneurysmal dilatation of the left atrial appendage. Circulation (1968) 1.44
Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain (1999) 1.42
Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982). Environ Health Perspect (1990) 1.41
Percutaneous transluminal angioplasty of stenotic saphenous vein right coronary bypass grafts utilizing a peripheral balloon dilatation catheter without a guiding catheter. Cathet Cardiovasc Diagn (1989) 1.40
Fatal left ventricular perforation following balloon mitral valvuloplasty. Can J Cardiol (1990) 1.40
Clinical utility of two dimensional echocardiography in infective endocarditis. Am J Cardiol (1980) 1.39
Angioplasty of isolated acute marginal coronary artery disease. Cathet Cardiovasc Diagn (1996) 1.39
Short- and long-term outcome of balloon angioplasty for compromised side branches after intracoronary stent deployment. Catheter Cardiovasc Interv (1999) 1.39
Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study. Ann Thorac Surg (1999) 1.39
The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project. Clin Infect Dis (2001) 1.38
Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis. Circulation (1971) 1.36
Diagnosis of left ventricular thrombi by two-dimensional echocardiography. Br Heart J (1979) 1.32
Clinical performance of Bjork-Shiley mechanical heart valves: a perspective on outlet strut fractures in the 60 degrees and 70 degrees convexo-concave disc models. Can J Cardiol (1988) 1.32
Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol (2000) 1.31
Lessons learned from independent central review. Eur J Cancer (2009) 1.30
Morphology of the human tricuspid valve. Circulation (1971) 1.28
Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. Circulation (1984) 1.26
Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation (1995) 1.26
The electrocardiogram in muscular subaortic stenosis. Effect of a left septal incision and right bundle-branch block. Circulation (1966) 1.26
Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol (1988) 1.23
Two dimensional echocardiographic assessment of patients with bioprosthetic valves. Am J Cardiol (1979) 1.21
Cardiac presentation of non-Hodgkin's lymphoma. Arch Pathol Lab Med (1987) 1.19
Hypertrophic cardiomyopathy: subclassification by m mode echocardiography. Am J Cardiol (1980) 1.18
A process evaluation of medical ethics education in the first year of a new medical curriculum. Med Educ (2000) 1.16
Risk factors for heterotopic ossification in total hip arthroplasty. Arch Orthop Trauma Surg (2001) 1.15
Mitral regurgitation in muscular subaortic stenosis. Am J Cardiol (1969) 1.15
Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Investig Med (1997) 1.15
Pharmacodynamics of mitral insufficiency in muscular subaortic stenosis. Can Med Assoc J (1967) 1.15
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer. J Clin Oncol (2001) 1.13
Impact of a new course on students' potential behaviour on encountering ethical dilemmas. Med Educ (2001) 1.12
Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. Heart (2003) 1.11
Dermatitis from Synthetic Resins and Waxes. Am J Public Health Nations Health (1936) 1.09
Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol (2001) 1.08
Prolapse of the posterior leaflet of the mitral valve associated with secundum atrial septal defect. Am J Cardiol (1975) 1.08
Mitral valve repair by replacement of chordae tendineae with polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg (1991) 1.08
Acute coronary artery occlusion during percutaneous transluminal coronary angioplasty treated by redilation of the occluded segment. J Am Coll Cardiol (1984) 1.07
Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development (1996) 1.07
Ventricular septal defect after myocardial infarction: diagnosis by two-dimensional contrast echocardiography. Circulation (1983) 1.07
Myocardial fiber disarray and ventricular septal hypertrophy in asymmetrical hypertrophy of the heart. Circulation (1978) 1.04
Left ventricular cineangiographic observations in muscular subaortic stenosis. Am J Cardiol (1969) 1.03
Atypical chest pain of cardiac and esophageal origin. Chest (1978) 1.03
Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl (2000) 1.02
Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br J Cancer (1990) 1.02
Localization of pericardial effusion with wide angle phased array echocardiography. Am J Cardiol (1978) 1.02
Muscular subaortic stenosis. The direct relation between the intraventricular pressure difference and the left ventricular ejection time. Circulation (1967) 1.01
Masseter spasm with anesthesia: incidence and implications. Anesthesiology (1984) 1.00
Carcinoid heart disease: diagnosis by two-dimensional echocardiography. Circulation (1982) 1.00
Do patient and physician expectations predict response to pain-relieving procedures? Clin J Pain (1997) 0.99
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol (2001) 0.99
Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg (2000) 0.99
A device to measure X-ray magnification in preoperative planning for cementless arthroplasty. Clin Orthop Relat Res (1986) 0.98
Idiopathic hypertrophic subaortic stenosis viewed by wide-angle, phased-array echocardiography. Circulation (1979) 0.98
Hypertrophic cardiomyopathy: when do you diagnose midventricular obstruction versus apical cavity obliteration with a small nonobliterated area at the apex of the left ventricle? J Am Coll Cardiol (1992) 0.98
Muscular subaortic stenosis: the initial left ventricular inflow tract pressure as evidence of outflow tract obstruction. Can Med Assoc J (1966) 0.98
Nosocomial legionellosis in surgical patients with head-and-neck cancer: implications for epidemiological reservoir and mode of transmission. Lancet (1985) 0.97
Cardiovascular drugs in muscular subaortic stenosis. Fed Proc (1966) 0.96
Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1991) 0.96
Angiographic-morphologic correlation in patients with severe mitral regurgitation due to prolapse of the posterior mitral valve leaflet. Circulation (1973) 0.96